'The Alliance' Discharged by Health Care B2B

 

The alliance among Ariba(ARBA), i2 Technologies(ITWO) and IBM(IBM) suffered its second setback in the past two weeks.

The trio, which calls itself The Alliance, lost out on providing the underlying technology for the Global Health Care Exchange. That exchange was announced last March by Johnson & Johnson(JNJ), GE Medical Systems, Baxter International(BAX), Abbott Laboratories(ABT) and Medtronic(MDT). It was formed for the $100 billion health care industry to buy and sell products online. And Ariba and its pals were tapped to provide the underlying technology, making the exchange their first joint customer.

The loss of the exchange as a customer comes a week after Ariba and i2 landed Transora, an Internet exchange in the food industry. But they did so without IBM, raising questions about The Alliance's strength.

Instead of Ariba, i2 and IBM, the health care exchange will use the technology of CentriMed, a company that focuses on exchange software for the health care industry. On Thursday, B2B incubator company Internet Capital Group (ICGE) brokered a deal to sell its stake in CentriMed to Global Health Care Exchange for a little over $30 million if certain conditions are met.

Thanks to that deal, the exchange decided to go with CentriMed's technology, said Jayson Page, a spokesman for the health care exchange.

Colleen Haikes, a spokeswoman for Ariba, i2 and IBM, disputes the notion that the development means the alliance is showing signs of weakness. Instead, she said, there still are opportunities for it to work in the health care exchange.

"The Global Health Care Exchange made a business decision to buy an existing marketplace with content and community. They're trying to establish the exchange with a homegrown solution," said Haikes. "Nevertheless, The Alliance is in discussion with the Global Health Care Exchange for opportunities to add value to the existing marketplace."

But losing an already announced customer hardly seems like a sign of strength.

>To order reprints of this article, click here: Reprints

TheStreet Premium Services    For Personal Service: 877-471-2967

Jim Cramer
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
New: ETF Profits
ETF Profits:
Get money-making ideas from the hottest investment vehicle on the planet. Our experts show you how to play various ETF sectors to help pump-up your portfolio. Learn More
OptionsProfits
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Doug Kass
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
Dow Jones S&P 500 NASDAQ 10-Year Note
12,890.46 1,351.95 2,927.23 20.47
Oil *
118.75
UP
6.51
UP
1.99
UP
11.37
UP
0.72
10 Yr
2.05%
SPDR Gold
168.02
+0.05%
+0.15%
+0.39%
+3.65%
Data delayed 20 minutes

Top Stories and Tools

Brokerage Partners

After the Bell

Before the Bell

Booyah! Newsletter

ETF Daily

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy.
Podcasts

Connect with TheStreet